aluates Reports

$ 0.0

Automative

Global PTCA Coronary Drug Eluting Balloons Market Research Report 2026

Published Date: 2026-01-22

Report Code: QYRE-Auto-27U9241

Global PTCA Coronary Drug Eluting Balloons Market Insights and Forecast to 2028

BUY CHAPTERS

Global PTCA Coronary Drug Eluting Balloons Market Research Report 2026

Code: QYRE-Auto-27U9241

Report

2026-01-22

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

B. Braun

Eurocor GmbH

Teleflex

Yinyi

PTCA Coronary Drug Eluting Balloons Market Size

The global PTCA Coronary Drug Eluting Balloons market was valued at US$ 709 million in 2025 and is anticipated to reach US$ 1738 million by 2032, at a CAGR of 13.5% from 2026 to 2032.

PTCA Coronary Drug Eluting Balloons Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PTCA Coronary Drug Eluting Balloons competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

PTCA coronary drug-eluting balloons—commonly referred to as coronary drug-coated/drug-eluting balloons (coronary DCB/DEB)—are angioplasty balloons used in percutaneous transluminal coronary angioplasty (PTCA) with an antiproliferative drug (predominantly paclitaxel, with growing “limus” exploration) plus an excipient/carrier layer on the balloon surface. During inflation, they provide immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic proposition is “leave nothing behind,” aiming to avoid additional permanent metal/polymer layers and preserve future treatment flexibility—most compelling in coronary in-stent restenosis (ISR), small-vessel disease, and selected bifurcation strategies. In 2025, global PTCA coronary drug-eluting balloons production reached approximately 755 k units and price is 940 USD/Unit.The average gross profit margin of this product is 73%.

A clear commercialization inflection has emerged: in March 2024, the U.S. FDA approved the first coronary drug-coated balloon for ISR (the AGENT DCB), significantly increasing global visibility and strengthening hospital adoption confidence. Concurrent randomized evidence and high-impact editorial perspectives reinforced the evidence base for ISR, accelerating the shift from experience-driven use to pathway-manageable standard practice. Over a longer horizon, coronary intervention is evolving from implant-centric approaches toward repair strategies that prioritize controllable reintervention, where DCBs benefit from a value narrative centered on reducing multilayer implants and long-term implant burden.

The key constraints are indication boundaries and reproducibility. Beyond ISR—where evidence is strongest—recent data in previously untreated, non-complex coronary disease did not support DCB as a straightforward substitute for second-generation DES as the preferred strategy, underscoring the need for tighter lesion selection, procedural standardization, and follow-up evidence as the market expands. Coronary anatomy also imposes higher demands on deliverability, coating integrity, and drug-transfer performance; batch variability can translate into outsized clinical experience and access risk. Combined with regional differences in combination-product regulation and hospital value assessment, manufacturers must build durable, repeatable capabilities across evidence, quality systems, and supply assurance.

Demand is shifting from single devices toward repeatable coronary repair solutions. Clinical practice increasingly emphasizes lesion preparation (adequate pre-dilation, managing calcium and dissection risk), intraprocedural assessment, and avoiding additional stent layers—clarifying DCB’s role in ISR, small vessels, and selected bifurcation strategies, often in combination with specialty balloons, plaque modification, and imaging guidance. With the U.S. entering a compliant “coronary DCB era,” ecosystem build-out around indication education, technique standardization, and real-world follow-up is accelerating, enabling hospitals to incorporate DCB into managed pathways and bundled device sets with greater predictability and scaling potential.

Upstream differentiation is ultimately a platform capability spanning materials, coating, and validation. Key inputs include balloon films and catheter polymers (multi-durometer shafts, liners, reinforcement braids/coils), drug APIs (paclitaxel or limus agents) with crystallinity/particle control, excipient and solvent systems, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Because coronary use is highly sensitive to particulate control, coating integrity, dose consistency, deliverability, and stability, the supply chain must operate with medical-grade traceability, clean manufacturing, robust change control, and strict release standards to industrialize “drug transfer + delivery performance + long-term stability” as a repeatable engineering capability.

This report delivers a comprehensive overview of the global PTCA Coronary Drug Eluting Balloons market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding PTCA Coronary Drug Eluting Balloons. The PTCA Coronary Drug Eluting Balloons market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global PTCA Coronary Drug Eluting Balloons market comprehensively. Regional market sizes by Type, by Application, by Use Scenario, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist PTCA Coronary Drug Eluting Balloons manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of PTCA Coronary Drug Eluting Balloons Market Report

Report Metric	Details
Report Name	PTCA Coronary Drug Eluting Balloons Market
Accounted market size in 2025	US$ 709 million
Forecasted market size in 2032	US$ 1738 million
CAGR	13.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Paclitaxel-based limus Other
Segment by Use Scenario	In-Stent Restenosi De novo Small Vessel
Segment by Balloon Platform Mechanics	Semi-/Compliant Non-compliant Other
by Application	Cardiac Catheterization Lab Hospital Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	B. Braun, Eurocor, Teleflex, Yinyi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Use Scenario, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for PTCA Coronary Drug Eluting Balloons manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines PTCA Coronary Drug Eluting Balloons sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is PTCA Coronary Drug Eluting Balloons Market growing?

Ans: The PTCA Coronary Drug Eluting Balloons Market witnessing a CAGR of 13.5% during the forecast period 2026-2032.

What is the PTCA Coronary Drug Eluting Balloons Market size in 2032?

Ans: The PTCA Coronary Drug Eluting Balloons Market size in 2032 will be US$ 1738 million.

Who are the main players in the PTCA Coronary Drug Eluting Balloons Market report?

Ans: The main players in the PTCA Coronary Drug Eluting Balloons Market are B. Braun, Eurocor, Teleflex, Yinyi

What are the Application segmentation covered in the PTCA Coronary Drug Eluting Balloons Market report?

Ans: The Applications covered in the PTCA Coronary Drug Eluting Balloons Market report are Cardiac Catheterization Lab, Hospital, Other

What are the Type segmentation covered in the PTCA Coronary Drug Eluting Balloons Market report?

Ans: The Types covered in the PTCA Coronary Drug Eluting Balloons Market report are Paclitaxel-based, limus, Other

1 PTCA Coronary Drug Eluting Balloons Market Overview

1.1 Product Definition

1.2 PTCA Coronary Drug Eluting Balloons by Type

1.2.1 Global PTCA Coronary Drug Eluting Balloons Market Value by Type: 2025 vs 2032

1.2.2 Paclitaxel-based

1.2.3 limus

1.2.4 Other

1.3 PTCA Coronary Drug Eluting Balloons by Use Scenario

1.3.1 Global PTCA Coronary Drug Eluting Balloons Market Value by Use Scenario: 2025 vs 2032

1.3.2 In-Stent Restenosi

1.3.3 De novo

1.3.4 Small Vessel

1.4 PTCA Coronary Drug Eluting Balloons by Balloon Platform Mechanics

1.4.1 Global PTCA Coronary Drug Eluting Balloons Market Value by Balloon Platform Mechanics: 2025 vs 2032

1.4.2 Semi-/Compliant

1.4.3 Non-compliant

1.4.4 Other

1.5 PTCA Coronary Drug Eluting Balloons by Application

1.5.1 Global PTCA Coronary Drug Eluting Balloons Market Value by Application: 2025 vs 2032

1.5.2 Cardiac Catheterization Lab

1.5.3 Hospital

1.5.4 Other

1.6 Global PTCA Coronary Drug Eluting Balloons Market Size Estimates and Forecasts

1.6.1 Global PTCA Coronary Drug Eluting Balloons Revenue 2021–2032

1.6.2 Global PTCA Coronary Drug Eluting Balloons Sales 2021–2032

1.6.3 Global PTCA Coronary Drug Eluting Balloons Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 PTCA Coronary Drug Eluting Balloons Market Competition by Manufacturers

2.1 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Manufacturers (2021–2026)

2.2 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Manufacturers (2021–2026)

2.3 Global PTCA Coronary Drug Eluting Balloons Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of PTCA Coronary Drug Eluting Balloons, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Product Types and Applications

2.7 Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Date of Entry into the Industry

2.8 Global PTCA Coronary Drug Eluting Balloons Market Competitive Situation and Trends

2.8.1 Global PTCA Coronary Drug Eluting Balloons Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global PTCA Coronary Drug Eluting Balloons Players Market Share by Revenue

2.8.3 Global PTCA Coronary Drug Eluting Balloons Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global PTCA Coronary Drug Eluting Balloons Market Scenario by Region

3.1 Global PTCA Coronary Drug Eluting Balloons Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global PTCA Coronary Drug Eluting Balloons Sales by Region: 2021–2032

3.2.1 Global PTCA Coronary Drug Eluting Balloons Sales by Region: 2021–2026

3.2.2 Global PTCA Coronary Drug Eluting Balloons Sales by Region: 2027–2032

3.3 Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2021–2032

3.3.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2021–2026

3.3.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2027–2032

3.4 North America PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.4.1 North America PTCA Coronary Drug Eluting Balloons Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America PTCA Coronary Drug Eluting Balloons Sales by Country (2021–2032)

3.4.3 North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.5.1 Europe PTCA Coronary Drug Eluting Balloons Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2021–2032)

3.5.3 Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Region

3.6.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2021–2032)

3.6.3 Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.7.1 Latin America PTCA Coronary Drug Eluting Balloons Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2021–2032)

3.7.3 Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.8.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2021–2032)

3.8.3 Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global PTCA Coronary Drug Eluting Balloons Sales by Type (2021–2032)

4.1.1 Global PTCA Coronary Drug Eluting Balloons Sales by Type (2021–2026)

4.1.2 Global PTCA Coronary Drug Eluting Balloons Sales by Type (2027–2032)

4.1.3 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2021–2032)

4.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2021–2032)

4.2.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2021–2026)

4.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2027–2032)

4.2.3 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2021–2032)

4.3 Global PTCA Coronary Drug Eluting Balloons Price by Type (2021–2032)

5 Segment by Application

5.1 Global PTCA Coronary Drug Eluting Balloons Sales by Application (2021–2032)

5.1.1 Global PTCA Coronary Drug Eluting Balloons Sales by Application (2021–2026)

5.1.2 Global PTCA Coronary Drug Eluting Balloons Sales by Application (2027–2032)

5.1.3 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2021–2032)

5.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2021–2032)

5.2.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2021–2026)

5.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2027–2032)

5.2.3 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2021–2032)

5.3 Global PTCA Coronary Drug Eluting Balloons Price by Application (2021–2032)

6 Key Companies Profiled

6.1 B. Braun

6.1.1 B. Braun Company Information

6.1.2 B. Braun Description and Business Overview

6.1.3 B. Braun PTCA Coronary Drug Eluting Balloons Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 B. Braun PTCA Coronary Drug Eluting Balloons Product Portfolio

6.1.5 B. Braun Recent Developments/Updates

6.2 Eurocor

6.2.1 Eurocor Company Information

6.2.2 Eurocor Description and Business Overview

6.2.3 Eurocor PTCA Coronary Drug Eluting Balloons Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Eurocor PTCA Coronary Drug Eluting Balloons Product Portfolio

6.2.5 Eurocor Recent Developments/Updates

6.3 Teleflex

6.3.1 Teleflex Company Information

6.3.2 Teleflex Description and Business Overview

6.3.3 Teleflex PTCA Coronary Drug Eluting Balloons Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Teleflex PTCA Coronary Drug Eluting Balloons Product Portfolio

6.3.5 Teleflex Recent Developments/Updates

6.4 Yinyi

6.4.1 Yinyi Company Information

6.4.2 Yinyi Description and Business Overview

6.4.3 Yinyi PTCA Coronary Drug Eluting Balloons Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Yinyi PTCA Coronary Drug Eluting Balloons Product Portfolio

6.4.5 Yinyi Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 PTCA Coronary Drug Eluting Balloons Industry Chain Analysis

7.2 PTCA Coronary Drug Eluting Balloons Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 PTCA Coronary Drug Eluting Balloons Production Mode & Process Analysis

7.4 PTCA Coronary Drug Eluting Balloons Sales and Marketing

7.4.1 PTCA Coronary Drug Eluting Balloons Sales Channels

7.4.2 PTCA Coronary Drug Eluting Balloons Distributors

7.5 PTCA Coronary Drug Eluting Balloons Customer Analysis

8 PTCA Coronary Drug Eluting Balloons Market Dynamics

8.1 PTCA Coronary Drug Eluting Balloons Industry Trends

8.2 PTCA Coronary Drug Eluting Balloons Market Drivers

8.3 PTCA Coronary Drug Eluting Balloons Market Challenges

8.4 PTCA Coronary Drug Eluting Balloons Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

B. Braun

Eurocor GmbH

Teleflex

Yinyi

List of Tables

Table 1. Global PTCA Coronary Drug Eluting Balloons Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global PTCA Coronary Drug Eluting Balloons Market Value by Use Scenario (US$ Million), 2025 vs 2032

Table 3. Global PTCA Coronary Drug Eluting Balloons Market Value by Balloon Platform Mechanics (US$ Million), 2025 vs 2032

Table 4. Global PTCA Coronary Drug Eluting Balloons Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global PTCA Coronary Drug Eluting Balloons Market Competitive Situation by Manufacturers in 2025

Table 6. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Manufacturers (2021–2026)

Table 8. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market PTCA Coronary Drug Eluting Balloons Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of PTCA Coronary Drug Eluting Balloons, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Product Types and Applications

Table 14. Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global PTCA Coronary Drug Eluting Balloons Companies by Tier (Tier 1, Tier 2, Tier 3), based on PTCA Coronary Drug Eluting Balloons Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global PTCA Coronary Drug Eluting Balloons Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global PTCA Coronary Drug Eluting Balloons Sales by Region (K Units), 2021–2026

Table 20. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2021–2026)

Table 21. Global PTCA Coronary Drug Eluting Balloons Sales by Region (K Units), 2027–2032

Table 22. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2027–2032)

Table 23. Global PTCA Coronary Drug Eluting Balloons Revenue by Region (US$ Million), 2021–2026

Table 24. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2021–2026)

Table 25. Global PTCA Coronary Drug Eluting Balloons Revenue by Region (US$ Million), 2027–2032

Table 26. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2027–2032)

Table 27. North America PTCA Coronary Drug Eluting Balloons Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2021–2026

Table 29. North America PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2027–2032

Table 30. North America PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2021–2026

Table 31. North America PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2027–2032

Table 32. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2021–2026

Table 34. Europe PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2027–2032

Table 35. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2021–2026

Table 36. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2021–2026

Table 44. Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2027–2032

Table 45. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (US$ Million), 2027–2032

Table 52. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Type (2021–2026)

Table 53. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Type (2027–2032)

Table 54. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2021–2026)

Table 55. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2027–2032)

Table 56. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Type (2021–2026)

Table 57. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Type (2027–2032)

Table 58. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2021–2026)

Table 59. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2027–2032)

Table 60. Global PTCA Coronary Drug Eluting Balloons Price (US$/Unit) by Type (2021–2026)

Table 61. Global PTCA Coronary Drug Eluting Balloons Price (US$/Unit) by Type (2027–2032)

Table 62. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Application (2021–2026)

Table 63. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Application (2027–2032)

Table 64. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2021–2026)

Table 65. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2027–2032)

Table 66. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Application (2021–2026)

Table 67. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Application (2027–2032)

Table 68. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2021–2026)

Table 69. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2027–2032)

Table 70. Global PTCA Coronary Drug Eluting Balloons Price (US$/Unit) by Application (2021–2026)

Table 71. Global PTCA Coronary Drug Eluting Balloons Price (US$/Unit) by Application (2027–2032)

Table 72. B. Braun Company Information

Table 73. B. Braun Description and Business Overview

Table 74. B. Braun PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. B. Braun PTCA Coronary Drug Eluting Balloons Product

Table 76. B. Braun Recent Developments/Updates

Table 77. Eurocor Company Information

Table 78. Eurocor Description and Business Overview

Table 79. Eurocor PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Eurocor PTCA Coronary Drug Eluting Balloons Product

Table 81. Eurocor Recent Developments/Updates

Table 82. Teleflex Company Information

Table 83. Teleflex Description and Business Overview

Table 84. Teleflex PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Teleflex PTCA Coronary Drug Eluting Balloons Product

Table 86. Teleflex Recent Developments/Updates

Table 87. Yinyi Company Information

Table 88. Yinyi Description and Business Overview

Table 89. Yinyi PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Yinyi PTCA Coronary Drug Eluting Balloons Product

Table 91. Yinyi Recent Developments/Updates

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. PTCA Coronary Drug Eluting Balloons Distributors List

Table 95. PTCA Coronary Drug Eluting Balloons Customers List

Table 96. PTCA Coronary Drug Eluting Balloons Market Trends

Table 97. PTCA Coronary Drug Eluting Balloons Market Drivers

Table 98. PTCA Coronary Drug Eluting Balloons Market Challenges

Table 99. PTCA Coronary Drug Eluting Balloons Market Restraints

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Product Picture of PTCA Coronary Drug Eluting Balloons

Figure 2. Global PTCA Coronary Drug Eluting Balloons Market Value by Type (US$ Million), 2021–2032

Figure 3. Global PTCA Coronary Drug Eluting Balloons Market Share by Type: 2025 & 2032

Figure 4. Paclitaxel-based Product Picture

Figure 5. limus Product Picture

Figure 6. Other Product Picture

Figure 7. Global PTCA Coronary Drug Eluting Balloons Market Value by Use Scenario (US$ Million), 2021–2032

Figure 8. Global PTCA Coronary Drug Eluting Balloons Market Share by Use Scenario: 2025 vs 2032

Figure 9. In-Stent Restenosi Product Picture

Figure 10. De novo Product Picture

Figure 11. Small Vessel Product Picture

Figure 12. Global PTCA Coronary Drug Eluting Balloons Market Value by Balloon Platform Mechanics (US$ Million), 2021–2032

Figure 13. Global PTCA Coronary Drug Eluting Balloons Market Share by Balloon Platform Mechanics: 2025 vs 2032

Figure 14. Semi-/Compliant Product Picture

Figure 15. Non-compliant Product Picture

Figure 16. Other Product Picture

Figure 17. Global PTCA Coronary Drug Eluting Balloons Market Value by Application (US$ Million), 2021–2032

Figure 18. Global PTCA Coronary Drug Eluting Balloons Market Share by Application: 2025 & 2032

Figure 19. Cardiac Catheterization Lab

Figure 20. Hospital

Figure 21. Other

Figure 22. Global PTCA Coronary Drug Eluting Balloons Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global PTCA Coronary Drug Eluting Balloons Market Size (US$ Million), 2021–2032

Figure 24. Global PTCA Coronary Drug Eluting Balloons Sales (K Units), 2021–2032

Figure 25. Global PTCA Coronary Drug Eluting Balloons Average Price (US$/Unit), 2021–2032

Figure 26. PTCA Coronary Drug Eluting Balloons Report Years Considered

Figure 27. PTCA Coronary Drug Eluting Balloons Sales Share by Manufacturers in 2025

Figure 28. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers in 2025

Figure 29. Top 5 and Top 10 Global PTCA Coronary Drug Eluting Balloons Players: Market Share by Revenue in PTCA Coronary Drug Eluting Balloons in 2025

Figure 30. PTCA Coronary Drug Eluting Balloons Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 31. Global PTCA Coronary Drug Eluting Balloons Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 32. North America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2021–2032)

Figure 33. North America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2021–2032)

Figure 34. U.S. PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Canada PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Europe PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2021–2032)

Figure 37. Europe PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2021–2032)

Figure 38. Germany PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. France PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. U.K. PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Italy PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Russia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2021–2032)

Figure 44. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2021–2032)

Figure 45. China PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Japan PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. South Korea PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. India PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Australia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Taiwan PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Indonesia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Thailand PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Malaysia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Philippines PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Latin America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2021–2032)

Figure 56. Latin America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2021–2032)

Figure 57. Mexico PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Brazil PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Argentina PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2021–2032)

Figure 61. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2021–2032)

Figure 62. Turkey PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Saudi Arabia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. UAE PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. Global Sales Market Share of PTCA Coronary Drug Eluting Balloons by Type (2021–2032)

Figure 66. Global Revenue Market Share of PTCA Coronary Drug Eluting Balloons by Type (2021–2032)

Figure 67. Global PTCA Coronary Drug Eluting Balloons Price (US$/Unit) by Type (2021–2032)

Figure 68. Global Sales Market Share of PTCA Coronary Drug Eluting Balloons by Application (2021–2032)

Figure 69. Global Revenue Market Share of PTCA Coronary Drug Eluting Balloons by Application (2021–2032)

Figure 70. Global PTCA Coronary Drug Eluting Balloons Price (US$/Unit) by Application (2021–2032)

Figure 71. PTCA Coronary Drug Eluting Balloons Value Chain

Figure 72. Channels of Distribution (Direct Vs Distribution)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Coated Balloons Market Insights Forecast to 2030

Coronary Intervention Drug Eluting Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug coated Balloon Dilatation Catheters Market Research Report 2025

Global Drug eluting PTA Balloon Dilatation Catheter Market Research Report 2025

Global Intracranial Drug Eluting Stents Market Research Report 2024

Global PTCA Coronary Balloon Catheter Market Research Report 2025

Global Coronary Artery Disease Treatment Devices Market Research Report 2025

Drug Eluting Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coronary PTCA Balloon Dilatation Catheters Market Research Report 2025

Drug Coated Balloon DCB Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ureteral Dilation Balloon Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pulmonary Embolism Drug Market Research Report 2025

Cardiac Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PTCA Dilatation Balloon Catheters Market Research Report 2025

Cardiovascular Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Coated PTA Balloon Catheter Market Research Report 2024

Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myocardial Infarction Drug Market Research Report 2024

Cardiovascular Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions